Soft Tissue Repair Articles & Analysis
17 news found
Today, MicroPort® is focused in covering ten major areas, including Cardiovascular Intervention & Structural Heart Diseases, Electrophysiology & Cardiac Rhythm Management, Orthopedics & Soft Tissue Repair, Endovascular & Peripheral Vascular Diseases, Neurovascular Intervention & Neurosciences, Life Sciences (Endocrine ...
ByRobocath
Today, MicroPort is focused in covering ten major areas, including cardiovascular intervention & structural heart diseases, electrophysiology & cardiac rhythm management, orthopedics & soft tissue repair, endovascular & peripheral vascular diseases, neurovascular intervention & neurosciences, life sciences (endocrine ...
ByRobocath
The four new patents relate to Biorez’s proprietary BioBrace Implant, which is a biocomposite soft tissue scaffold intended to reinforce soft tissue repair, and act as a biologic scaffold to promote healing. ...
Biorez Inc., a New Haven start-up advancing tendon and ligament healing, announced today that it has received 510(k) clearance from the Food and Drug Administration (FDA) for two sizes of its BioBrace Implant. This new biocomposite soft tissue scaffold is intended to be used in a broad range of surgical procedures to reinforce soft ...
” “Implants that are bioinductive while providing structure for healing tissues during the repair or reconstruction continuum is the natural progression with this type of technology and I am looking forward to working with our surgeons to deliver the best-in-class implant for their practice and their patients,” commented Mr. ...
BioBridge is a sterile, biocompatible and biodegradable device made of medical-grade collagen that has 510(k) clearance from the FDA for use as a surgical mesh to reinforce and support soft tissue repair. In this study BioBridge will be implanted as part of the lymph node transplant surgery to support repair of damaged lymphatic ...
“I have spent most of my career evaluating new technologies in orthopedics and have long awaited an implant that can meaningfully improve soft tissue healing,” said Dr. Pachuda. “Biorez has developed a regenerative scaffold that can reinforce soft tissue repair, improve healing, and naturally ...
Lymphedema can ultimately lead to irreversible structural changes in the tissues, which can result in severe deformity, serious reduction in function and have a profound impact on quality-of-life. ...
BioBridge is classified as a Class III device with an indication for use to support lymphatic tissue repair and can be used after or in conjunction with surgical procedures addressing lymphedema. ...
This novel medical device is commercially available in the US and has 510(k) clearance from the FDA for use in surgery to reinforce and repair soft tissue where weakness and deficiencies exist. Published preclinical studies and early clinical usage have shown that BioBridge supports the repair of damaged lymphatic vessels, a ...
Food and Drug Administration (FDA) for CoronetTM System, a tenodesis product intended for the fixation of tissue to bone and tissue to tissue. The Coronet’s novel design improves the soft tissue fixation strength of these repairs compared to conventional suture repairs. A ...
CoNextions Medical, a developer of novel soft tissue repair devices, announced today that it has completed enrollment in a key clinical trial for its pioneering tendon-to-tendon repair device, CoNextions TR. ...
The scope of the certification is for the design, development, manufacture and distribution of porcine collagen scaffold implants used for soft tissue repair and support, nerve repair, wound/scar management, orthopedics, vascular, ophthalmic and lymphatic therapeutic areas. ...
” Dan Gruppo stated, “It is never easy to leave a large company with a track record of success, such as Stryker, but after meeting the people at CoNextions Medical and seeing the CoNextions TR™ tendon approximation and soft tissue repair system and their future pipeline, it was clear that I had to join the team. The ...
In conjunction with its formation, Colibri has granted Colorado Therapeutics a license to develop and market innovative and disruptive xenogenic (sourced from different mammalian species) biologic tissue matrix products for a broad range of soft tissue reinforcement, regenerative, and vascular applications outside of structural heart. Colorado ...
In conjunction with its formation, Colibri has granted Colorado Therapeutics a license to develop and market innovative and disruptive xenogenic (sourced from different mammalian species) biologic tissue matrix products for a broad range of soft tissue reinforcement, regenerative, and vascular applications outside of structural heart. Colorado ...
CoNextions TR has been designed to provide several advantages over the current suture-based repair which is the standard of care, including: stronger repair strength to enable early active motion; consistent and standardized outcomes; a simpler and faster surgical technique; and an improved quality of recovery for patients. ...